ArticleJournal of inflammation research2026
Development of a Prognostic Nomogram Model and Establishment of a Risk Stratification System Based on the Naples Prognostic Score for Patients with Oropharyngeal Squamous Cell Carcinoma Who Have Undergone Radical Surgery.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Naples prognostic score (NPS), a comprehensive indicator of inflammation and nutritional status, has demonstrated favorable prognostic predictive value in a multitude of malignant tumors. Nevertheless, its clinical significance in oropharyngeal squamous cell carcinoma (OPSCC) remains ambiguous. Methods: This is a multicenter retrospective investigation encompassing 372 patients with OPSCC who underwent radical surgery from August 2010 to September 2020. The univariate and multivariate Cox regression analyses were conducted to screen the independent prognostic factors influencing disease - free survival (DFS) and overall survival (OS). Based on these analyses, two prognostic nomogram incorporating the NPS was constructed. The predictive performance of the models was evaluated using the concordance index (C - index), receiver operating characteristic curve (ROC), calibration curve, decision curve analysis (DCA), integrated discrimination improvement index (IDI), and net reclassification index (NRI). A risk stratification system was further established according to the total risk score of the nomograms, and the survival benefit of adjuvant radiotherapy in different risk subgroups was analyzed. Results: Multivariate analysis indicated that AJCC stage, p16 expression status, perineural invasion, NPS, and age - adjusted Charlson comorbidity index (ACCI) were independent prognostic factors for DFS and OS. The constructed DFS and OS nomograms demonstrated stable prediction performance in both the training and validation sets, with C - indexes of 0.661 and 0.665, respectively, and the area under the ROC curve was greater than 0.65. The calibration curve revealed that the prediction results of the model were in good agreement with the actual observation results. DCA demonstrated that the model had a higher net clinical benefit than the AJCC staging system. The IDI and NRI analyses further corroborated the significant advantages of the new model in discrimination power and risk reclassification. The analysis based on the risk stratification system indicated that adjuvant radiotherapy was significantly associated with survival benefit only in the high - risk group, while no significant benefit was observed in the intermediate - risk and low - risk groups. Conclusion: NPS is an important independent prognostic indicator for DFS and OS in postoperative OPSCC patients. The incorporation of NPS into the nomogram can enhance the accuracy of survival prediction and offer a reference for personalized medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.